HOMCY CHARLES J 4
4 · BridgeBio Pharma, Inc. · Filed Jun 23, 2026
Research Summary
AI-generated summary of this filing
BridgeBio (BBIO) Director Charles Homcy Withholds 788 Shares for Taxes
What Happened
Charles J. Homcy, a director of BridgeBio Pharma (BBIO), had 788 shares of common stock withheld on 2026-06-20 to satisfy his tax obligation related to the vesting of RSUs. The withheld shares were valued at $66.27 each, for a total of about $52,221. This was a tax-withholding action, not an open-market sale or purchase.
Key Details
- Transaction date: 2026-06-20; Filing date: 2026-06-23 (Form 4 accession 0001470831-26-000569).
- Withheld: 788 shares at $66.27 per share; total value ≈ $52,221.
- Footnote: Those 788 shares were withheld to cover taxes on the vesting of 2,196 RSU shares.
- Shares owned after transaction: Not stated in the provided filing.
- Filing timeliness: No late-filing indicator provided in the summarized data.
Context
Share withholding to cover taxes is a routine administrative action when RSUs vest. It is effectively a cashless method of satisfying tax withholding and does not necessarily signal the insider is selling additional shares or changing their investment view. For investors, purchases or outright open-market sales tend to be more informative about insider sentiment than tax-withholding events.
Insider Transaction Report
- Tax Payment
Common Stock
[F1]2026-06-20$66.27/sh−788$52,221→ 915,886 total
Footnotes (1)
- [F1]Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 2,196 shares of Common Stock underlying the Reporting Person's RSUs.